An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine.
作者信息
Baldessarini R J, Neumeyer J L, Campbell A, Sperk G, Ram V J, Arana G W, Kula N S
出版信息
Eur J Pharmacol. 1982 Jan 8;77(1):87-8. doi: 10.1016/0014-2999(82)90543-x.
PMID:6277658
Abstract
摘要
相似文献
1
An orally effective, long-acting dopaminergic prodrug: (-)-10,11-methylenedioxy-N-propylnoraporphine.
Eur J Pharmacol. 1982 Jan 8;77(1):87-8. doi: 10.1016/0014-2999(82)90543-x.
2
Tissue levels of N-n-propylnorapomorphine after treatment with (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally long-acting prodrug active at central dopamine receptors.
Neuropharmacology. 1982 Dec;21(12):1311-6. doi: 10.1016/0028-3908(82)90139-3.
3
Behavioral effects of (-)10,11-methylenedioxy-N-n-propylnoraporphine, an orally effective long-acting agent active at central dopamine receptors, and analogous aporphines.
Neuropharmacology. 1982 Oct;21(10):953-61. doi: 10.1016/0028-3908(82)90106-x.
4
S(+)methylenedioxy-N-n-propylnoraporphine: an orally active inhibitor of dopamine selective for rat limbic system.
Brain Res. 1987 Feb 17;403(2):393-7. doi: 10.1016/0006-8993(87)90083-7.
5
Pre- and post-synaptic dopaminergic receptors involved in apomorphine-induced yawning.
Acta Neurobiol Exp (Wars). 1982;42(2):115-25.
6
Comparison of the dopaminergic effects of apomorphine and (-)-N-n-propylnorapomorphine.
Eur J Pharmacol. 1978 Nov 1;52(1):1-9. doi: 10.1016/0014-2999(78)90015-8.
7
Behavioural effects of drugs acting on the central dopaminergic neurons.
Act Nerv Super (Praha). 1977 Jul;19 Suppl 2:335-6.
8
Behavioral effects of apomorphine and diisobutyrylapomorphine in the mouse.
Psychopharmacology (Berl). 1977 Jun 6;53(1):45-53. doi: 10.1007/BF00426693.
9
(-)-10,11-Methylenedioxy-N-propylnoraporphine, an orally effective dopamine agonist and duodenal antiulcerogen in the rat.
Eur J Pharmacol. 1983 Mar 25;88(2-3):273-4. doi: 10.1016/0014-2999(83)90018-3.
10
Chronic electroconvulsive shock and chronic haloperidol administration are not additive in effects on dopamine receptors.
Neuropharmacology. 1981 Nov;20(11):1125-8. doi: 10.1016/0028-3908(81)90107-6.
引用本文的文献
1
3,4-disubstituted phenyliminoimidazolidines as potential prodrugs of the purported dopamine agonist 3,4-dihydroxyphenylimino-2-imidazolidine (DPI).
Pharm Weekbl Sci. 1983 Aug 26;5(4):177-81. doi: 10.1007/BF01961477.
2
Comparative assessment of dopamine agonist aporphines as anticonvulsants in two models of reflex epilepsy.
Psychopharmacology (Berl). 1983;81(2):135-9. doi: 10.1007/BF00429007.
Zotero 插件